DarioHealth
DRIO
10 hedge funds and large institutions have $401K invested in DarioHealth in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
9% less funds holding
Funds holding: 11 → 10 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
32% less capital invested
Capital invested by funds: $587K → $401K (-$186K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$30.2K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.1K |
| 3 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$26K |
| 4 |
JP Morgan Chase
New York
|
+$1.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$75K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$45.8K |
| 3 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$2K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$2K |
DRIO Hedge Fund Activity: Q2 2017 in Review
10 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2017, worth a combined $401K — down 32% from $587K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DRIO and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $30.2K. The largest seller was Morgan Stanley, exiting entirely with an estimated $75K sold.
- 10 institutional investors held DarioHealth (DRIO) as of Q2 2017, down from 11 in Q1 2017.
- Funds reported $401K of DarioHealth stock for Q2 2017, down 32% quarter-over-quarter.
- 3 funds opened new DarioHealth positions in Q2 2017 and 4 closed out, a net change of -1 holder.
- The largest DarioHealth buyer in Q2 2017 was Millennium Management, an estimated $30.2K added.
- The largest DarioHealth seller in Q2 2017 was Morgan Stanley, an estimated $75K sold.
Based on aggregated 13F filings for Q2 2017.